Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laszlo Radvanyi

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2014
Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical developmentGeok Choo Sim, Jessica Chacon, Cara Haymaker, et al.
Cancer Research|November 25, 2010
Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cellsNatalia Martin-Orozco, Yufeng Li, Yijun Wang, et al.
Hormones & Cancer|July 16, 2011
Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cellsShoulei Jiang, Hiroshi Katayama, Jin Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapyShujuan Liu, Tamara Etto, Tania Rodríguez-Cruz, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2006
HLA-A0201 positive pancreatic cell lines: new findings and discrepanciesKuichun Zhu, Gregory Lizee, Pedro Cano, et al.
Plos One|April 6, 2013
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapyJessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, et al.
Cancer Research|August 24, 2012
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokinesWeiyi Peng, Chengwen Liu, Chunyu Xu, et al.
Frontiers in Immunology|March 9, 2023
VISTA expression and patient selection for immune-based anticancer therapyAlexander S Martin, Michael Molloy, Andrey Ugolkov, et al.
Cancer Research|July 18, 2008
Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patientsFeng Wang-Johanning, Laszlo Radvanyi, Kiera Rycaj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyJessica Ann Chacon, Amod A Sarnaik, Jie Qing Chen, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2014
Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical developmentGeok Choo Sim, Jessica Chacon, Cara Haymaker, et al.
Cancer Research|November 25, 2010
Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cellsNatalia Martin-Orozco, Yufeng Li, Yijun Wang, et al.
Hormones & Cancer|July 16, 2011
Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cellsShoulei Jiang, Hiroshi Katayama, Jin Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapyShujuan Liu, Tamara Etto, Tania Rodríguez-Cruz, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2006
HLA-A0201 positive pancreatic cell lines: new findings and discrepanciesKuichun Zhu, Gregory Lizee, Pedro Cano, et al.
Plos One|April 6, 2013
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapyJessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, et al.
Cancer Research|August 24, 2012
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokinesWeiyi Peng, Chengwen Liu, Chunyu Xu, et al.
Frontiers in Immunology|March 9, 2023
VISTA expression and patient selection for immune-based anticancer therapyAlexander S Martin, Michael Molloy, Andrey Ugolkov, et al.
Cancer Research|July 18, 2008
Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patientsFeng Wang-Johanning, Laszlo Radvanyi, Kiera Rycaj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapyJessica Ann Chacon, Amod A Sarnaik, Jie Qing Chen, et al.
Pageof 6